Montelukast Prescribing at THE DE PARYS GROUP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,324
Total Quantity
91.4K
NHS Cost
£4.5K
vs National Avg
+239.4%
THE DE PARYS GROUP prescribed 2,324 items of Montelukast over the last 12 months at a cost of £4,492 to the NHS. This is 239.4% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
197
Jun 2026
188
Jun 2026
210
Jun 2026
197
Jun 2026
188
Jun 2026
194
Jun 2026
197
Jun 2026
229
Jun 2026
182
Jun 2026
165
Jun 2026
200
Jun 2026
177
Prescribing Details
| Total Items | 2,324 |
|---|---|
| Total Quantity | 91,399 |
| Total NHS Cost | £4,492 |
| Presentations | 4 different forms |
| vs National Average | +239.4% |
Montelukast Prescribing Comparison
| This practice | 2,324 items |
|---|---|
| National average per practice | 685 items |
| Difference | +239.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.